Buy Glenmark Pharmaceuticals Limited and Cadila Healthcare Limited

buy26

Buy Glenmark Pharmaceuticals Limited:

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Ltd has officially announced a consolidated sales of Rs. 2,801.85 Cr for the third quarter finished on 31-12-2020, which is 4.07% down from its previous quarter sales of Rs. 2,920.60 Cr and 1.20% up from its previous year same quarter sales of Rs. 2,768.52 Cr. The company has reported a net profit after tax of Rs. 248.18 Cr in the previous quarter.

Outlook:

Glenmark Pharmaceuticals Ltd: Experts suggested buy call at current market price: Rs. 577.80 with a target price: Rs. 588; Stoploss: Rs. 574.

Buy Cadila Healthcare Limited:

 

Cadila Healthcare Limited

 

Cadila Healthcare Ltd has officially announced a consolidated sales of Rs. 3,795.60 Cr for the third quarter finished on 31-12-2020, which is 0.64% up from its previous quarter sales of Rs. 3,820 Cr and 7.39% up from its previous year same quarter sales of Rs. 3,534.50 Cr. The company has reported net profit after tax of Rs. 512.50 Cr in the previous quarter.

Outlook:

Cadila Healthcare Ltd: Experts suggested buy call at current market price: Rs. 580.80 with a target price: Rs. 590; Stoploss: Rs. 578.

Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.

Leave a Reply

Your email address will not be published. Required fields are marked *